Drug Trial Radar · NCT00093925
Clevidipine in the Postoperative Treatment of Hypertension (ECLIPSE-NIC)
Last checked: Nov 20, 2026Latest source record: May 6, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
739
Actual
Start
May 2004
Primary completion
Jul 2006
Study completion Sep 2006
Sponsor
- Lead sponsor
- The Medicines CompanyIndustry
- Sponsor type
- Industry
- First posted
- Oct 8, 2004
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to establish the safety of clevidipine in the treatment of postoperative hypertension. Approximately 250-500 patients with postoperative hypertension after undergoing coronary artery bypass grafting (CABG), off-pump coronary artery bypass (OPCAB) or minimally invasive direct coronary artery bypass (MIDCAB) surgery and/or valve replacement/repair procedures were anticipated to be randomly assigned to one of two treatment groups: clevidipine or nicardipine.
Conditions
- Hypertension
Interventions
clevidipineDrug
nicardipineDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of death, stroke, MI, and renal dysfunctionTime frame: Initiation of study drug infusion through post-operative Day 30
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
Mobile Infirmary Medical Center
Mobile, Alabama
Wesley Medical Center
Wichita, Kansas
Touro Infirmary
New Orleans, Louisiana
Ochsner Clinic Foundation
New Orleans, Louisiana
Columbia University - College of Physicians and Surgeons
New York, New York
Jack D. Weller Hospital
The Bronx, New York
Montefiore Medical Center
The Bronx, New York
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
VA Medical Center McGuire
Richmond, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.